Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,495
Closed -$899K 1343
2025
Q3
$899K Sell
7,495
-125
-2% -$13.2K 0.07% 333
2025
Q2
$700K Buy
7,620
+1,755
+30% +$160K 0.07% 351
2025
Q1
$516K Buy
+5,865
New +$577K 0.04% 509
2024
Q3
Sell
-5,771
Closed -$433K 1324
2024
Q2
$433K Buy
+5,771
New +$460K 0.03% 605
2024
Q1
Sell
-4,507
Closed -$312K 1347
2023
Q4
$312K Buy
4,507
+245
+6% +$14.8K 0.02% 721
2023
Q3
$233K Buy
+4,262
New +$242K 0.02% 815
2018
Q1
Sell
-15,000
Closed -$541K 1536
2017
Q4
$541K Buy
+15,000
New +$537K 0.04% 400
2017
Q2
Sell
-700
Closed -$25K 1634
2017
Q1
$25K Buy
+700
New +$24.4K ﹤0.01% 1238
2016
Q4
Sell
-3,700
Closed -$123K 1581
2016
Q3
$123K Buy
3,700
+3,500
+1,750% +$111K 0.01% 748
2016
Q2
$6K Buy
+200
New +$5.86K ﹤0.01% 1442

Other funds holding CRH

Prelude Capital Management's CRH Position: Q4 2025 in Review

Prelude Capital Management sold out of CRH (CRH) in Q4 2025, closing a stake of 7,495 shares — an estimated $899K sold.

Prelude Capital Management first reported a position in CRH in Q2 2016 and held it in 10 quarters. The position peaked at $899K in Q3 2025. 1,009 funds tracked by Wall St. Rank hold CRH as of Q4 2025.

  • Prelude Capital Management reported no remaining CRH position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 7,495 CRH shares in Q4 2025, an estimated $899K.
  • Prelude Capital Management first reported a position in CRH in Q2 2016 and held it in 10 quarters.
  • Prelude Capital Management's CRH position peaked at $899K in Q3 2025.
  • 1,009 funds tracked by Wall St. Rank held CRH as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.